Article

Impact of the SARS-CoV-2 Delta Variant Versus Pre-Delta Variants In Non-Hospitalized Children

2022-01-04

Abstract excerpt

Background: The prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents at a population level remains unclear, especially as the Delta (B.1.617.2) variant became predominant in the United States in July 2021. Furthermore, symptom status by variant time period (pre-Delta vs. Delta) and by antibody serostatus is not well described in non-hospitalized pediatric...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c552b9c2-9f90-539f-ab90-1897689eedd1
DOI: 10.2139/ssrn.4000449

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Impact of the SARS-CoV-2 Delta Variant Versus Pre-Delta Variants In Non-Hospitalized ChildrenDOI 10.2139/ssrn.4000449Read

Whole genome analysis reveals unique traits of SARS-CoV-2 in pediatric patients.Semantic proximity Read

The role of SARS-CoV-2 variants of concern in children and adolescents with COVID-19: a systematic reviewSemantic proximity Read

Illness characteristics of COVID-19 in children infected with the SARS-CoV-2 Delta variantSemantic proximity Read

Estimated Prevalence of SARS-CoV-2 Antibodies in the Texas Pediatric Population, 2021Semantic proximity Read

Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated IndividualsSemantic proximity Read

Predictive value of isolated symptoms for diagnosis of SARS-CoV-2 infection in children tested during peak circulation of the delta variantSemantic proximity Read

Post COVID-19 Condition after Delta Infection and Omicron Reinfection in Children and AdolescentsSemantic proximity Read

Surveillance genome sequencing reveal multiple SARS-CoV-2 variants circulating in the central Texas, USA with a predominance of Delta variant and review of vaccine breakthrough casesSemantic proximity Read

SARS-CoV2 Wild-type and Delta VOC infection dynamics in a Paediatric cohort in India (South)Semantic proximity Read

Protection against symptomatic disease with the delta and omicron BA.1/BA.2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, EnglandSemantic proximity Read

Delta Variant SARS-CoV-2 infections in pediatric cases during the second wave in IndiaSemantic proximity Read

Characteristics and clinical features of SARS-CoV-2 infections among ambulatory and hospitalized children and adolescents in an integrated health care system in TennesseeSemantic proximity Read